Keyphrases
Clinical Parameters
100%
Fatigue Assessment Scale
100%
Pulmonary Sarcoidosis
100%
Fatigue Parameters
100%
Sarcoidosis
80%
Significant Predictors
20%
Maastricht
20%
Outpatient Clinic
20%
Dutch Population
20%
Clinical Variables
20%
Sex Differences
20%
High-sensitivity C-reactive Protein (hs-CRP)
20%
Disease Severity
20%
Delayed Diagnosis
20%
Lung Function Tests
20%
Physiological Variables
20%
Pulmonary Disease
20%
Work Study
20%
University Hospital
20%
Serum Amyloid A
20%
Fatigue Index
20%
Soluble interleukin-2 Receptor (sIL-2R)
20%
Response Marker
20%
Control Population
20%
Acute Phase Response
20%
Angiotensin-converting Enzyme
20%
Metabolic Derangements
20%
Sarcoidosis Activity
20%
Serological Parameters
20%
Activity Parameters
20%
Medicine and Dentistry
Sarcoidosis
100%
Lung Sarcoidosis
100%
C Reactive Protein
20%
Acute Phase Response
20%
Silo-Filler's Disease
20%
Disease Severity
20%
Lung Function Test
20%
Outpatient
20%
Dipeptidyl Carboxypeptidase
20%
Serum Amyloid A
20%
Soluble Interleukin 2 Receptor
20%
Sex Difference
20%
DLCO
20%
Population Dynamics
20%
Nursing and Health Professions
Sarcoidosis
100%
Lung Sarcoidosis
100%
Disease Severity
20%
University Hospital
20%
Lung Function Test
20%
Outpatient Department
20%
Lung Disease
20%
C Reactive Protein
20%
Dipeptidyl Carboxypeptidase
20%
Serum Amyloid A
20%
Soluble Interleukin 2 Receptor
20%
Gender Difference
20%
INIS
fatigue
100%
patients
41%
assessments
41%
populations
16%
diseases
8%
lungs
8%
values
8%
sensitivity
8%
control
8%
tools
8%
receptors
8%
comparative evaluations
8%
sex
8%
hospitals
8%
enzymes
8%
universities
8%
c-reactive protein
8%
interleukins
8%
angiotensin
8%
Pharmacology, Toxicology and Pharmaceutical Science
Sarcoidosis
100%
Lung Sarcoidosis
100%
C Reactive Protein
20%
Lung Disease
20%
Serum Amyloid A
20%
Soluble Interleukin 2 Receptor
20%
Disease Severity
20%
Dipeptidyl Carboxypeptidase
20%
Neuroscience
Sarcoidosis
100%
C-Reactive Protein
16%
Dipeptidyl Carboxypeptidase
16%
Serum Amyloid A
16%
Soluble Interleukin 2 Receptor
16%